Trevor Richter

Trevor Richter is an experienced professional in the pharmaceutical and healthcare industries, currently serving as Executive Director at BioCryst Pharmaceuticals, Inc. since August 2023. Prior to this role, Trevor held various leadership positions at Gilead Sciences, including Director of Access and Reimbursement from June 2021 to July 2023, and spent over a decade at CADTH in multiple capacities, notably as Director of Pharmaceutical Reviews and Director of Common Drug Review and Optimal Use. Earlier in the career, Trevor gained valuable experience at Pfizer Canada as a Regional Medical and Research Specialist and held research positions at The Ottawa Hospital, University of Miami, and University of Wisconsin - Madison. Trevor earned a PhD in Neuroscience from the University of Cambridge and an MSc in Physiology from the University of Pretoria.